LOXL2, Human (Simtuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-LOXL2, Human (Simtuzumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityLOXL2, Human (Simtuzumab biosimilar)
CloneSimtuzumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG4 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsFCM, IP, ELISA, Neut, FuncS
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human LOXL2 Recombinant Antibody. Simtuzumab (INN, formerly GS 6624) is a humanized monoclonal antibody designed for the treatment of fibrosis. It binds to LOXL2 and acts as an immunomodulator. In January 2016, Gilead Sciences terminated its Phase 2 clinical study in patients with idiopathic pulmonary fibrosis (IPF) due to lack of efficacy.
Immunogenn/a
Other NamesAnti-LOXL2 Recombinant Antibody, Research Grade Simtuzumab, Anti-Human LOXL2 Recombinant Antibody, AB0024, GS-6624, Antibody Drug Analogues, Monoclonal Antibody, YR1290, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1318075-13-6
Catalog #YR1290
Priceplease inquire
Order / More InfoLOXL2, Human (Simtuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.